Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
m (→Also known as) |
m |
||
Line 10: | Line 10: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3"> | <div style="column-count:3;-moz-column-count:3;-webkit-column-count:3"> | ||
+ | *[[Acquired coagulopathy]] | ||
*[[Adult T-cell leukemia-lymphoma]] | *[[Adult T-cell leukemia-lymphoma]] | ||
*[[Anaplastic large cell lymphoma]] | *[[Anaplastic large cell lymphoma]] | ||
− | |||
*[[B-cell acute lymphoblastic leukemia]] | *[[B-cell acute lymphoblastic leukemia]] | ||
+ | **[[B-cell acute lymphoblastic leukemia, Ph-positive, pediatric]] | ||
+ | *[[B-cell lymphoma of mucosa-associated lymphoid tissue]] | ||
*[[Burkitt lymphoma]] | *[[Burkitt lymphoma]] | ||
*[[Chronic lymphocytic leukemia]] | *[[Chronic lymphocytic leukemia]] | ||
− | |||
*[[Diffuse large B-cell lymphoma]] | *[[Diffuse large B-cell lymphoma]] | ||
*[[Erdheim-Chester disease]] | *[[Erdheim-Chester disease]] | ||
*[[Follicular lymphoma]] | *[[Follicular lymphoma]] | ||
+ | *[[High-grade glioma, pediatric]] | ||
*[[HIV-associated lymphoma]] | *[[HIV-associated lymphoma]] | ||
*[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | *[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | ||
*[[Hodgkin lymphoma]] | *[[Hodgkin lymphoma]] | ||
+ | *[[Immune thrombocytopenia (ITP)]] | ||
*[[Langerhans cell histiocytosis]] | *[[Langerhans cell histiocytosis]] | ||
*[[Large granular lymphocytic leukemia]] | *[[Large granular lymphocytic leukemia]] | ||
− | |||
*[[Mantle cell lymphoma]] | *[[Mantle cell lymphoma]] | ||
*[[Marginal zone lymphoma]] | *[[Marginal zone lymphoma]] | ||
Line 33: | Line 35: | ||
*[[Myelodysplastic syndrome]] | *[[Myelodysplastic syndrome]] | ||
*[[Myelofibrosis]] | *[[Myelofibrosis]] | ||
+ | *[[Non-Hodgkin lymphoma, pediatric]] | ||
*[[Peripheral T-cell lymphoma]] | *[[Peripheral T-cell lymphoma]] | ||
*[[Post-transplant lymphoproliferative disorder]] | *[[Post-transplant lymphoproliferative disorder]] | ||
*[[Primary mediastinal B-cell lymphoma]] | *[[Primary mediastinal B-cell lymphoma]] | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
+ | *[[Smoldering multiple myeloma]] | ||
*[[T-cell acute lymphoblastic leukemia]] | *[[T-cell acute lymphoblastic leukemia]] | ||
*[[Thymoma]] | *[[Thymoma]] | ||
Line 44: | Line 48: | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
*[[Breast cancer - historical|Breast cancer]] | *[[Breast cancer - historical|Breast cancer]] | ||
+ | *[[Light-chain (AL) amyloidosis - historical|Light-chain (AL) amyloidosis]] | ||
+ | *[[Medulloblastoma - historical|Medulloblastoma]] | ||
==Patient drug information== | ==Patient drug information== | ||
Line 179: | Line 185: | ||
[[Category:Langerhans cell histiocytosis medications]] | [[Category:Langerhans cell histiocytosis medications]] | ||
[[Category:Large granular lymphocytic leukemia medications]] | [[Category:Large granular lymphocytic leukemia medications]] | ||
− | [[Category: | + | [[Category:MALT lymphoma medications]] |
[[Category:Mantle cell lymphoma medications]] | [[Category:Mantle cell lymphoma medications]] | ||
[[Category:Marginal zone lymphoma medications]] | [[Category:Marginal zone lymphoma medications]] | ||
Line 190: | Line 196: | ||
[[Category:Primary mediastinal B-cell lymphoma medications]] | [[Category:Primary mediastinal B-cell lymphoma medications]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
+ | [[Category:Smoldering multiple myeloma medications]] | ||
[[Category:T-cell acute lymphoblastic leukemia medications]] | [[Category:T-cell acute lymphoblastic leukemia medications]] | ||
[[Category:Thymoma medications]] | [[Category:Thymoma medications]] | ||
[[Category:Transformed lymphoma medications]] | [[Category:Transformed lymphoma medications]] | ||
[[Category:Waldenström macroglobulinemia medications]] | [[Category:Waldenström macroglobulinemia medications]] | ||
+ | |||
+ | [[Category:Breast cancer medications (historic)]] | ||
+ | [[Category:Light-chain (AL) amyloidosis medications (historic)]] | ||
+ | [[Category:Medulloblastoma medications (historic)]] | ||
[[Category:FDA approved in 1955]] | [[Category:FDA approved in 1955]] |
Revision as of 19:54, 25 April 2022
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Acquired coagulopathy
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- B-cell acute lymphoblastic leukemia
- B-cell lymphoma of mucosa-associated lymphoid tissue
- Burkitt lymphoma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Erdheim-Chester disease
- Follicular lymphoma
- High-grade glioma, pediatric
- HIV-associated lymphoma
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Hodgkin lymphoma
- Immune thrombocytopenia (ITP)
- Langerhans cell histiocytosis
- Large granular lymphocytic leukemia
- Mantle cell lymphoma
- Marginal zone lymphoma
- Mast cell diseases
- Mediastinal gray-zone lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
- Myelofibrosis
- Non-Hodgkin lymphoma, pediatric
- Peripheral T-cell lymphoma
- Post-transplant lymphoproliferative disorder
- Primary mediastinal B-cell lymphoma
- Prostate cancer
- Smoldering multiple myeloma
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Waldenström macroglobulinemia
Diseases for which it was used
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
Also known as
- Generic names: pred
- Brand names:
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Artinizona | Artrizona | Becortem | Bersen | Colisone | Cortancyl | Corticorten | Cortigen |
Cortiol | Cortiprex | Cutason | Dacortin | Decortancyl | Decortin | Decortisyl | Dehydrocortison |
Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan | Deltacortene | Deltacortone | Deltason | Deltasone |
Deltisona | Dispersona | Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten |
Hostacortin | Ifison | Isolone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednisona | Prednisonum |
Prednitone | Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison |
Rayos | Rectodelt | Senterlic | Sone | Steerometz | Sterapred | Trolic | Ultracorten |
Vitazon | Winpred |
References
Categories:
- Drugs
- Oral medications
- Immunosuppressants
- Steroids
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia medications
- Acquired coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenia medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- MALT lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- Smoldering multiple myeloma medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- Breast cancer medications (historic)
- Light-chain (AL) amyloidosis medications (historic)
- Medulloblastoma medications (historic)
- FDA approved in 1955